Orakl Oncology: Funding, Investors & Team (Sep 2026)
Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered analysis. The company utilizes a distinct collection of patient tumor avatars that integrates both biological and clinical data to enhance cancer treatment options.
Orakl Oncology has raised $11.5M across 1 funding round on record, the most recent a Seed of $11.5M announced in Dec 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Orakl Oncology Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Orakl Oncology Funding Rounds
Orakl Oncology Founders and Leadership Team
Contact details for the Orakl Oncology team: 1 of 1 has an email address on file.
Start 14-day free trial →Orakl Oncology Funding Compared to Other Biotechnology Startups
Orakl Oncology's latest round of $11.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Orakl Oncology in Biotechnology and Villejuif
Companies Similar to Orakl Oncology
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Orakl Oncology Funding FAQs
What does Orakl Oncology do?
Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered analysis. The company utilizes a distinct collection of patient tumor avatars that integrates both biological and clinical data to enhance cancer treatment options.
How much funding has Orakl Oncology raised?
Orakl Oncology has raised $11.5M across 1 round on record. The most recent is a Seed of $11.5M announced in Dec 2024.
When did Orakl Oncology last raise funding?
Orakl Oncology's most recent funding round on record is a Seed of $11.5M, announced in Dec 2024.
Who founded Orakl Oncology?
FundedIQ lists Gustave Ronteix (Founder) at Orakl Oncology.
Where is Orakl Oncology headquartered?
Orakl Oncology is based in Villejuif, Ile-De-France, France.
How many employees does Orakl Oncology have?
Orakl Oncology is in the 1-10 employee band.
How does Orakl Oncology's funding compare to other Biotechnology startups?
Orakl Oncology's latest round of $11.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Orakl Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Orakl Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.